Related references
Note: Only part of the references are listed.Safety and effectiveness of SGM-101, a fluorescent antibody targeting carcinoembryonic antigen, for intraoperative detection of colorectal cancer: a dose-escalation pilot study
Leonora S. F. Boogerd et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2018)
Perioperative systemic therapy for resectable colorectal peritoneal metastases: Sufficient evidence for its widespread use? A critical systematic review
Koen P. Rovers et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2017)
Clinicopathological Parameters in Patient Selection for Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Cancer Metastases A Meta-analysis
Riom Kwakman et al.
ANNALS OF SURGERY (2016)
Prospective Quality of Life Study for Colorectal Cancer Patients with Peritoneal Carcinomatosis Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
Claramae Shulyn Chia et al.
ANNALS OF SURGICAL ONCOLOGY (2016)
Bevacizumab in Addition to Palliative Chemotherapy for Patients With Peritoneal Carcinomatosis of Colorectal Origin: A Nationwide Population-Based Study
Lieke G. E. M. Razenberg et al.
CLINICAL COLORECTAL CANCER (2016)
Progress in treatments for colorectal cancer peritoneal metastases during the years 2010-2015. A systematic review
Dario Baratti et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2016)
Challenging the dogma of colorectal peritoneal metastases as an untreatable condition: Results of a population-based study
Lieke G. E. M. Razenberg et al.
EUROPEAN JOURNAL OF CANCER (2016)
Complete Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastasis in Norway: Prognostic Factors and Oncologic Outcome in a National Patient Cohort
Ida S. Froysnes et al.
JOURNAL OF SURGICAL ONCOLOGY (2016)
Intraoperative imaging of folate receptor alpha positive ovarian and breast cancer using the tumor specific agent EC17
Quirijn R. J. G. Tummers et al.
ONCOTARGET (2016)
Molecular fluorescence-guided surgery of peritoneal carcinomatosis of colorectal origin: a single-centre feasibility study
Niels J. Harlaar et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2016)
Prognostic Similarities and Differences in Optimally Resected Liver Metastases and Peritoneal Metastases From Colorectal Cancers
Dominique Elias et al.
ANNALS OF SURGERY (2015)
Colorectal peritoneal carcinomatosis treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: The experience of a tertiary Asian center
Melissa Ching Ching Teo et al.
ASIAN JOURNAL OF SURGERY (2015)
Incidence and treatment of recurrent disease after cytoreductive surgery and intraperitoneal chemotherapy for peritoneally metastasized colorectal cancer: A systematic review
T. R. van Oudheusden et al.
EJSO (2015)
In Vivo Fluorescence Immunohistochemistry: Localization of Fluorescently Labeled Cetuximab in Squamous Cell Carcinomas
Esther de Boer et al.
SCIENTIFIC REPORTS (2015)
Serious Postoperative Complications Affect Early Recurrence After Cytoreductive Surgery and HIPEC for Colorectal Peritoneal Carcinomatosis
Geert A. Simkens et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Reconciliation of classification systems defining molecular subtypes of colorectal cancer
Anguraj Sadanandam et al.
CELL CYCLE (2014)
Postoperative Complications After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Affect Long-term Outcome of Patients With Peritoneal Metastases From Colorectal Cancer: a Two-Center Study of 101 Patients
D. Baratti et al.
DISEASES OF THE COLON & RECTUM (2014)
Cytoreductive Surgery and Hyperthermic Intra-Peritoneal Chemotherapy Treatment of Colorectal Peritoneal Metastases: Cohort Analysis of High Volume Disease and Cure Rate
Peter H. Cashin et al.
JOURNAL OF SURGICAL ONCOLOGY (2014)
Patterns of recurrence following complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer
Hidde J. Braam et al.
JOURNAL OF SURGICAL ONCOLOGY (2014)
Is There a Possibility of a Cure in Patients With Colorectal Peritoneal Carcinomatosis Amenable to Complete Cytoreductive Surgery and Intraperitoneal Chemotherapy?
Diane Goere et al.
ANNALS OF SURGERY (2013)
Cytoreduction and HIPEC in The Netherlands: Nationwide Long-term Outcome Following the Dutch Protocol
Anke M. J. Kuijpers et al.
ANNALS OF SURGICAL ONCOLOGY (2013)
Risk factors for recurrence following complete cytoreductive surgery and HIPEC in colorectal cancer-derived peritoneal surface malignancies
Ingmar Koenigsrainer et al.
LANGENBECKS ARCHIVES OF SURGERY (2013)
Poor-prognosis colon cancer is defined by a molecularly distinct subtype and develops from serrated precursor lesions
Felipe De Sousa E Melo et al.
NATURE MEDICINE (2013)
A colorectal cancer classification system that associates cellular phenotype and responses to therapy
Anguraj Sadanandam et al.
NATURE MEDICINE (2013)
Gene Expression Classification of Colon Cancer into Molecular Subtypes: Characterization, Validation, and Prognostic Value
Laetitia Marisa et al.
PLOS MEDICINE (2013)
The Treatment of Peritoneal Carcinomatosis of Colorectal Cancer with Complete Cytoreductive Surgery and Hyperthermic Intraperitoneal Peroperative Chemotherapy (HIPEC) with Oxaliplatin: A Belgian Multicentre Prospective Phase II Clinical Study
Daphne Hompes et al.
ANNALS OF SURGICAL ONCOLOGY (2012)
Incidence, prevalence and risk factors for peritoneal carcinomatosis from colorectal cancer
J. Segelman et al.
BRITISH JOURNAL OF SURGERY (2012)
Survival and Quality of Life Following Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis of Colonic Origin
Adrienne R. Hill et al.
ANNALS OF SURGICAL ONCOLOGY (2011)
Predictors and survival of synchronous peritoneal carcinomatosis of colorectal origin: a population-based study
Valery E. Lemmens et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-α targeting: first in-human results
Gooitzen M. van Dam et al.
NATURE MEDICINE (2011)
Evaluation of Best Supportive Care and Systemic Chemotherapy as Treatment Stratified according to the retrospective Peritoneal Surface Disease Severity Score (PSDSS) for Peritoneal Carcinomatosis of Colorectal Origin
Joerg O. W. Pelz et al.
BMC CANCER (2010)
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemoperfusion Versus Systemic Chemotherapy Alone for Colorectal Peritoneal Carcinomatosis
Jan Franko et al.
CANCER (2010)
Peritoneal Colorectal Carcinomatosis Treated With Surgery and Perioperative Intraperitoneal Chemotherapy: Retrospective Analysis of 523 Patients From a Multicentric French Study
Dominique Elias et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Should the Treatment of Peritoneal Carcinomatosis by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Still be Regarded as a Highly Morbid Procedure? A Systematic Review of Morbidity and Mortality
Terence C. Chua et al.
ANNALS OF SURGERY (2009)
The Clavien-Dindo Classification of Surgical Complications Five-Year Experience
Pierre A. Clavien et al.
ANNALS OF SURGERY (2009)
Complete Cytoreductive Surgery Plus Intraperitoneal Chemohyperthermia With Oxaliplatin for Peritoneal Carcinomatosis of Colorectal Origin
Dominique Elias et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
8-year follow-up of randomized trial: Cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer
Vic J. Verwaal et al.
ANNALS OF SURGICAL ONCOLOGY (2008)
Monitoring health outcomes following cytoreductive surgery plus intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis
Richard P. McQuellon et al.
ANNALS OF SURGICAL ONCOLOGY (2007)
Toxicity and quality of life after cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy
Todd M. Tuttle et al.
ANNALS OF SURGICAL ONCOLOGY (2006)
Peritoneal carcinomatosis of colorectal origin - Incidence and current treatment strategies
MJ Koppe et al.
ANNALS OF SURGERY (2006)
Perioperative morbidity and quality of life in long-term survivors following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
U Schmidt et al.
EJSO (2005)
Long-term survival of peritoneal carcinomatosis of colorectal origin
VJ Verwaal et al.
ANNALS OF SURGICAL ONCOLOGY (2005)
Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: A multi-institutional study
O Glehen et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Long-term survivorship and quality of life after cytoreductive surgery plus intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis
RP McQuellon et al.
ANNALS OF SURGICAL ONCOLOGY (2003)
Peritoneal carcinomatosis from colorectal cancer
DG Jayne et al.
BRITISH JOURNAL OF SURGERY (2002)
Quality of life after intraperitoneal hyperthermic chemotherapy (IPHC) for peritoneal carcinomatosis
RP McQuellon et al.
EUROPEAN JOURNAL OF SURGICAL ONCOLOGY (2001)
Share Paper
